Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearch for a tirzepatide calculator online and you'll find tools promising to predict your dose, your mix, or your results before you've spoken to a single clinician. Some are genuinely useful references. Others are built for compounded tirzepatide — a grey-market product that is not licensed in the UK. Here's what these calculators are actually doing, what they're based on, and why certain questions they leave open can only be answered by a prescriber reviewing your full picture. Tirzepatide is a prescription-only medicine in the UK; no calculator replaces that clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most of the calculators surfacing on this query (peptide ratio tools, mixing guides, BAC water calculators) originate from communities using compounded tirzepatide. Compounded tirzepatide is a preparation made outside the licensed supply chain, typically supplied as a powder or vial that the user reconstitutes themselves. In that context, a tirzepatide mixing calculator has a practical purpose: working out how many milligrams are in each drawn syringe.
In the UK, that calculation is irrelevant for patients using licensed treatment. Mounjaro (the brand name for tirzepatide authorised by the MHRA) comes as a pre-filled KwikPen. Each pen contains four weekly doses at a fixed strength. You dial, inject, and the device handles the rest. There is no powder, no vial, no syringe to fill. A BAC water calculator designed for reconstitution simply has no application here.
What you might legitimately want is a tool that helps you think about your starting BMI, expected trajectory, or how the titration schedule maps onto your timeline. A Mounjaro weight loss calculator in that sense is a rough planning aid, the kind of thing that helps frame a conversation with a clinician, not replace one. Treat any numerical output as illustrative, not predictive.
This is where a common misconception is worth gently setting aside. Many people arrive at these tools believing that if they input their weight, height, and current dose, the calculator will tell them whether they're ready to step up. That's not how tirzepatide titration works, and it's not what these tools are designed to do.
The licensed titration schedule for Mounjaro starts at 2.5 mg. The purpose of that opening period is tolerability, letting your system adjust before any meaningful therapeutic effect is expected. From there, increases typically happen in 4-week steps, guided by how well you're tolerating each dose, not by a formula. A tirzepatide ratio calculator can't know whether you've been experiencing nausea, how your weight has moved, or what your medical history looks like. A prescriber can.
According to the NHS tirzepatide guidance, dose changes should be managed by the clinician overseeing your care. At nume, that means a GPhC-registered Independent Prescriber reviews your case before any repeat or dose increase, a person reading your notes, not software running an equation.
Some tools attempt to project weight loss based on trial data. There's a kernel of legitimacy here. SURMOUNT-1, published in the New England Journal of Medicine, found that participants on 15 mg tirzepatide lost an average of around 20–21% of body weight over 72 weeks, a figure cited by NICE's appraisal of tirzepatide (TA1026) as part of its recommendation. Plugging your starting weight into a calculator based on that average produces a number. The number isn't meaningless.
What it can't reflect is the distribution around that average. Some people in the trial lost considerably more; others considerably less. A calculator has no access to the factors that influence where you land: baseline metabolic rate, the presence of conditions like type 2 diabetes, how closely you pair treatment with dietary change, or which dose you ultimately tolerate. The average is a population statistic. You are not a population. A peptide calculator for tirzepatide built on those averages gives you a reference point, not a promise.
Framing those projections as goals rather than rough context is where some tools stray. Clinical trials are the evidence base, not a ceiling or a floor for any individual. Explore the broader tirzepatide overview for a grounded summary of what the evidence actually shows.
For anyone considering tirzepatide for weight management in the UK, the route begins with a clinical consultation, not a calculator. You can read about the licensed UK product in more detail on the Mounjaro page; the short version is that it's licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea.
Pricing is another practical question people use calculators to try to answer in advance. An honest overview of what private tirzepatide treatment costs and what's typically included is covered on the Mounjaro prices page, useful context before a consultation.
The consultation itself at a regulated UK pharmacy is the point where a prescriber maps your medical history, current medicines, and goals against what the treatment can realistically offer. That's a clinical conversation, and the starting point is free. If you'd like to find out whether tirzepatide is suitable for you, check your eligibility with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.